Table 5.
Clinical trial data on complement system inhibitors in COVID-19.
| Drug Under Investigation | Aim of The Trial. | Status of Clinical Trial | Location | Results from The Trial | References |
|---|---|---|---|---|---|
| Eculizumab | To assess whether by modulating the activity of immune response with Eculizumab, can mortality be halted while the patient has time to recover from the virus with supportive medical care. | Recruiting | United States, France | No results posted | [103] |